The pet diabetes care devices market is projected to grow at a CAGR of 6.5% during the forecast period 2025 to 2033, driven by rising awareness of pet health, increasing rates of obesity in companion animals, and growing owner interest in preventive care. Diabetes mellitus is becoming more prevalent among pets, especially dogs and cats, resulting in a strong demand for home-monitoring tools and veterinary solutions that enhance long-term disease management. Innovative devices for continuous glucose monitoring, insulin administration, and digital health tracking offer pet owners new levels of convenience, accuracy, and assurance. Rising pet insurance adoption and ongoing veterinary innovations also support the positive long-term outlook for this segment.
Market Drivers
Increasing Prevalence of Diabetes in Companion Animals
Pet obesity and sedentary lifestyles contribute to a greater incidence of insulin-resistant diabetes in dogs and cats. This ongoing trend enhances demand for accurate and easy-to-use diagnostic tools, insulin delivery devices, and glucose monitors tailored for companion animals.
Advancements in Homecare and Monitoring Technologies
The growing availability of compact, wireless glucose monitors and insulin pens simplifies at-home management of diabetic pets. Advances in wearable trackers and app-based tools allow owners and veterinarians to monitor pet glucose levels continuously, detect anomalies early, and optimize insulin dosing with minimal stress to the pet.
Rising Emphasis on Preventive and Personalized Veterinary Care
Veterinary professionals and pet owners are increasingly focusing on personalized care regimens and early diagnostics to manage chronic diseases. This focus supports strong demand for specialized veterinary devices that enhance at-home care and reduce the need for frequent clinic visits.
Market Restraint
High Device and Care Costs in Developing Regions
Despite broad awareness and technological progress, the high price of insulin, glucose monitoring devices, and veterinary visits restricts uptake in lower-income regions. Additionally, pet owners may lack adequate knowledge and access to specialized veterinary infrastructure, limiting sustained device adoption in some developing economies.
Market Segmentation by Animal Type
The Animal Type segment includes Dogs, Cats, and Horses. Dogs accounted for the largest market share in 2024, supported by their higher prevalence of diabetes and pet owners’ willingness to spend on quality care. Cats follow closely, driven by increasing diagnoses of obesity and related endocrine disorders. Horses, while a smaller segment, present specialized care requirements for insulin sensitivity and metabolic syndromes, supporting moderate growth in specialized equine diabetes management tools.
Market Segmentation by End Use
By End Use, the market is segmented into Veterinary Hospitals and Clinics, Homecare Settings, and Other End Uses. Veterinary hospitals and clinics led the market in 2024 owing to their role in initial diagnosis, long-term care planning, and specialized diabetic management. Homecare settings are projected to register the highest CAGR during 2025 to 2033 as owners embrace wearable continuous glucose monitors and insulin pens for daily home use. Other end uses, including research institutions and pet-sitting services, contribute to market demand by utilizing basic diagnostic tools and remote monitoring solutions to manage diabetic pets under supervised care.
Geographic Trends
North America accounted for the largest market share in 2024 due to strong awareness of pet health, increasing insurance coverage for diabetic care, and widespread adoption of pet-monitoring devices. Europe followed closely as pet care regulations and veterinary expertise continue to evolve across Germany, the UK, and France. The Asia Pacific region is projected to show the most rapid growth through 2033, driven by increased pet ownership rates, improvements in veterinary care infrastructure, and higher disposable incomes in countries like China, India, Japan, and South Korea. Latin America and the Middle East & Africa present emerging opportunities as awareness of veterinary diagnostics grows and specialized clinics continue to improve service offerings.
Competitive Landscape
The pet diabetes care devices market is competitive, with key companies including Allison Medical, ALR Technologies, Becton, Dickinson and Company, Boehringer Ingelheim, FitBark, Henry Schein Animal Health, i-SENS, MED TRUST, Merck Animal Health, TaiDoc, Trividia Health, UltiMed, and Zoetis. Leading players focus on continuous innovation and product diversification to strengthen their positions. Merck Animal Health and Zoetis leverage broad veterinary networks to enhance distribution, while companies like Becton, Dickinson and Company and i-SENS drive innovation with advanced sensor technologies and precision insulin administration tools. FitBark and ALR Technologies cater to the growing demand for wireless monitoring solutions that sync with mobile apps and enable real-time data sharing with veterinarians. Competitive strategies also include partnerships with pet insurers and specialty vet clinics, as well as increasing investments in R&D to enhance device usability, accuracy, and affordability. Expansion into emerging markets with tailored offerings will remain a key focus to unlock future growth opportunities across diverse geographies.
Historical & Forecast Period
This study report represents analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Pet Diabetes Care Devices market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2023-2033 |
| Base Year | 2024 |
| Forecast Period | 2025-2033 |
| Historical Year | 2023 |
| Unit | USD Million |
| Segmentation | |
Device Type
| |
Animal Type
| |
End Use
| |
|
Region Segment (2023-2033; US$ Million)
|
Key questions answered in this report
